Hangzhou DAC Biotech Co., Ltd is based in Hangzhou, Zhejiang, China. It has raised $156M in total funding. Latest round: Series C.
Hangzhou DAC Biotech Co., Ltd is based in Hangzhou, Zhejiang, China. Hangzhou DAC Biotech Co., Ltd has raised $156M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for Hangzhou DAC Biotech Co., Ltd runs through 2022; nothing later has been disclosed. Investors on record include Johnson & Johnson Development Corporation.
Totals shown for Hangzhou DAC Biotech Co., Ltd aggregate every disclosed round on file. To see how that compares, browse the companies in Hangzhou and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026